NCT00065767View on ClinicalTrials.gov

Cognitive and Neurophysiological Effects of Raloxifene in Alzheimer's Disease

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 30, 2001

Primary Completion Date

March 31, 2005

Study Completion Date

March 31, 2005

Conditions
Alzheimer Disease
Interventions
DRUG

Raloxifene

Trial Locations (1)

53705

University of Wisconsin Memory Research Program, Madison

All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

lead

University of Wisconsin, Madison

OTHER

NCT00065767 - Cognitive and Neurophysiological Effects of Raloxifene in Alzheimer's Disease | Biotech Hunter | Biotech Hunter